S. 2057 (IS) - Pharmaceutical Regulation Conflict of Interest Act - BILLS-115s2057is | Content Details | GovInfo

Skip to main content

Start of main content

S. 2057 (IS) - Pharmaceutical Regulation Conflict of Interest Act

Category: Bills and Statutes

Collection: Congressional Bills

SuDoc Class Number: Y 1.6:
Y 1.4/1:

Congress Number: 115th Congress

Congress Session: 1st Session

Last Action Date Listed: November 1, 2017

Action: Ms. Baldwin (for herself, Mrs. Feinstein, Ms. Harris, Ms. Hassan, Mr. Markey, Mrs. Shaheen, and Mr. Udall) introduced the following bill; which was read twice and referred to the Committee on Homeland Security and Governmental Affairs

Bill Number: S. 2057

Bill Version: Introduced in Senate (IS)

Short Title: Pharmaceutical Regulation Conflict of Interest Act

Full Title: To prevent conflicts of interest that stem from the revolving door that raises concerns about the independence of pharmaceutical regulators.

Sponsors: Tammy Baldwin(WI)

Cosponsors: Dianne Feinstein (CA); Kamala D. Harris (CA); Margaret Wood Hassan (NH); Edward J. Markey (MA); Jeanne Shaheen (NH); Tom Udall (NM)

Committees: Committee on Homeland Security and Governmental Affairs (Standing)

United States Code References: 2 U.S.C. 1602 and 4702
18 U.S.C. 207
19 U.S.C. 2171(b)(4)
21 U.S.C. 321
25 U.S.C. 450i, 5304 and 5323
42 U.S.C. 2297h-3 and 262
49 U.S.C. 106(p)(6)(I)(ii)